Today, Benj Gallander and David Burrows commented about whether HES-N, ISRG-Q, XPO-N, X-N, CGX-T, MU-Q, LRCX-Q, ATD.B-T, URI-N, WMT-N, IPL-T, BNS-T, SQM-N, MG-T, CCL.B-T, ENB-T, XSU-T, IRTC-O, AMAT-Q, SQ-N, CDI-T, BB-T, QTRH-T, CET-T, OBE-T, GMP-T, CGX-T, BRB-T, QSR-T, BXE-T, HLF-T, CCE-X, AEG-N, BRK.A-N, LB-T, BBOX-O, BOS-T are stocks to buy or sell.
They make a skin patch to monitor for irregular heartbeats then indicates on an app whether there are heart issues. Patient incomes are 3x as good as the next-best technology. This captures only 6% of the U.S. market and not international yet. IRTC did not break down during the recent correection. Strong.
Pipelines have been suffering the past year, because they are less economically sensitive stocks during an accelerating economy. So, investors are shifting money into other sectors that are accelerating. Enbridge isn't benefitting from the oil rally. (Buy Suncor or CNQ for that.) You'll get your dividend and this is a well-run company, but ENB is a good house in a bad neighbourhood.
Revenues have gone up 82% last year and they have a new line of credit. The rig count is rising and the payment per day has gone up dramatically. He thinks this could trade back into the double-digits. He doesn’t know where oil prices will go, but it seems reasonably priced. Yield 0%. (Analysts’ price target is $2.38 )